pmc logo image
Logo of amjpatholAmerican Journal of Pathology For AuthorsAmerican Journal of Pathology SubscribeAmerican Journal of Pathology SearchAmerican Journal of Pathology Current IssueAmerican Journal of Pathology About the JournalAmerican Journal of Pathology

Formats:

Am J Pathol. 1980 December; 101(3): 557–580.
PMCID: PMC1903661
Kappa light chain glomerulosclerosis in multiple myeloma.
A. E. Seymour, A. J. Thompson, P. S. Smith, A. J. Woodroffe, and A. R. Clarkson
Abstract
Kappa light chains were demonstrated by immunofluorescence microscopy in the renal basement membranes of 6 of 10 patients with multiple myeloma subjected to kidney biopsy. Nodular glomerulosclerosis was present in 2 of these patients, but the remainder showed only minor light microscopic abnormalities. Deposition of kappa light chains in renal basement membranes may be a frequent cause of kidney disease in multiple myeloma. This deposition may be detected with electron microscopy by the demonstration of granular dense transformation of basement membranes. Occasionally there is systemic vascular deposition of kappa light chains which may be difficult to distinguish from amyloid but lacks a fibrillar character. The tissue effects of light chains in multiple myeloma seem likely to be more extensive than their deposition in renal tubules. There appears to be a greater tendency for kappa light chains to accumulate in renal and systemic basement membranes, but the mechanisms governing this deposition are unknown.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (5.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Schubert GE, Adam A. Glomerular nodules and long-spacing collagen in kidneys of patients with multiple myeloma. J Clin Pathol. 1974 Oct;27(10):800–805. [PubMed]
  • Randall RE, Williamson WC, Jr, Mullinax F, Tung MY, Still WJ. Manifestations of systemic light chain deposition. Am J Med. 1976 Feb;60(2):293–299. [PubMed]
  • Clarkson AR, Seymour AE, Thompson AJ, Haynes WD, Chan YL, Jackson B. IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol. 1977 Nov;8(5):459–471. [PubMed]
  • Hijmans W, Schuit HR, Klein F. An immunofluorescence procedure for the detection of intracellular immunoglobulins. Clin Exp Immunol. 1969 Apr;4(4):457–472. [PubMed]
  • Terashima K, Takahashi K, Kojima M, Imai Y, Tsuchida S, Migita S, Ebina S, Itoh C. Kappa-type light chain crystal storage histiocytosis. Acta Pathol Jpn. 1978 Jan;28(1):111–138. [PubMed]
  • Johnson WJ, Kyle RA, Dahlberg PJ. Dialysis in the treatment of multiple myeloma. Mayo Clin Proc. 1980 Feb;55(2):65–72. [PubMed]
  • Clyne DH, Pesce AJ, Thompson RE. Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point. Kidney Int. 1979 Sep;16(3):345–352. [PubMed]
  • Strober W, Waldmann TA. The role of the kidney in the metabolism of plasma proteins. Nephron. 1974;13(1):35–66. [PubMed]
  • Solomon A. Bence-Jones proteins and light chains of immunoglobulins (second of two parts). N Engl J Med. 1976 Jan 8;294(2):91–98. [PubMed]
  • Kyle RA, Greipp PR. 3. The laboratory investigation of monoclonal gammopathies. Mayo Clin Proc. 1978 Nov;53(11):719–739. [PubMed]
  • Shustik C, Bergsagel DE, Pruzanski W. Kappa and lambda light chain disease: survival rates and clinical manifestations. Blood. 1976 Jul;48(1):41–51. [PubMed]
  • Mackenzie MR, Wuepper KD, Jordan G, Fudenberg HH. Rapid renal failure in a case of multiple myeloma: the role of Bence Jones proteins. Clin Exp Immunol. 1968 Jul;3(6):593–601. [PubMed]
  • Wehner H, Feurer F, Wehner I. Histometrical glomerular studies on the kidneys in multiple myeloma and in acute membranous glomerulonephritis (lipoid nephrosis). Pathol Eur. 1971;6(4):422–432. [PubMed]
  • Schubert GE, Veigel J, Lennert K. Structure and function of the kidney in multiple myeloma. Virchows Arch A Pathol Pathol Anat. 1972;355(2):135–157. [PubMed]
  • KOBERNICK SD, WHITESIDE JH. Renal glomeruli in multiple myeloma. Lab Invest. 1957 Sep–Oct;6(5):478–485. [PubMed]
  • SANCHEZ LM. DOMZ CA: Renal patterns in myeloma. Ann Intern Med. 1960 Jan;52:44–54. [PubMed]
  • Solling K, Askjaer SA. Multiple myeloma with urinary excretion of heavy chain components of IgG and nodular glomerulosclerosis. Acta Med Scand. 1973 Jul–Aug;1-2(1):23–30. [PubMed]
  • Olsen S. Mesangial thickening and nodular glomerular sclerosis in diabetes mellitus and other diseases. Acta Pathol Microbiol Scand Suppl. 1972;233:203–216. [PubMed]
  • King JT, Valenzuela R, McCormack LJ, Osborne DG. Granular dense deposit disease. Lab Invest. 1978 Dec;39(6):591–596. [PubMed]
  • Vladutiu AO, Kohli RK, Prezyna AP. Monoclonal IgE with renal failure. Am J Med. 1976 Dec;61(6):957–962. [PubMed]
  • Herf S, Pohl SL, Sturgill B, Bolton WK. An evaluation of diabetic and pseudodiabetic glomerulosclerosis. Am J Med. 1979 Jun;66(6):1040–1045. [PubMed]
  • Stekhoven JH, van Haelst UJ. Unusual findings in the human renal glomerulus in multiple myeloma. A light- and electron-microscopic study. Virchows Arch B Cell Pathol. 1971;9(4):311–321. [PubMed]
  • Kawano K, Arakawa M, McCoy J, Porch J, Kimmelstiel P. Quantitative study of glomeruli. Focal glomerulonephritis and diabetic glomerulosclerosis. Lab Invest. 1969 Sep;21(3):269–275. [PubMed]
  • Bloodworth JM., Jr A re-evaluation of diabetic glomerulosclerosis 50 years after the discovery of insulin. Hum Pathol. 1978 Jul;9(4):439–453. [PubMed]
  • Ward AM, Preston FE. The kidney and intravascular coagulation in myelomatosis. Br Med J. 1974 Jun 8;2(5918):529–531. [PubMed]
  • Franklin EC. Some unsolved problems in the amyloid diseases. Am J Med. 1979 Mar;66(3):365–367. [PubMed]